PERIGON Japan Trial

NCT02686814 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2024-04-12

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the safety and effectiveness of the 17mm MDT-2215 aortic valve bioprosthesis.

Conditions

  • Aortic Stenosis

Interventions

DEVICE

17mm MDT-2215 aortic valve bioprosthesis

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY
  • Medtronic Cardiac Surgery

    lead INDUSTRY

Principal Investigators

  • Yutaka Okita, MD · Kobe University Hospital, Japan

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2018-05-31
Completion
2022-07-15

Countries

  • Japan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02686814 on ClinicalTrials.gov